GLP-1 weight-loss drugs, such as Ozempic, have become increasingly integrated into American healthcare, with support from the current administration. In an exclusive interview with Fox News Digital at the Great American State Fair in Washington D.C. on July 6, CMS Administrator Dr. Mehmet Oz expressed his endorsement of GLP-1 medications for appropriate use.

"They do help people who are overweight lose weight quite effectively. They're not a replacement for diet and exercise, but they might jumpstart the system so it’s easier for you to use healthier tactics," Oz said. He emphasized that these drugs are particularly beneficial for individuals who have difficulty moving due to joint pain or internal dysfunction.

Dr. Oz also pointed out that obesity is the top driver of healthcare costs, stating, "We think about 70% of all the money we spend on healthcare is caused by chronic conditions, and obesity is the No. 1 driver of all that, so it’s a smart decision."

Highlighting the potential cost savings, he added, "We believe these are so effective in reducing conditions like high blood pressure and diabetes that they'll actually save money for the federal taxpayer, because [they're] going to make you healthy enough that you don't have to consume health services."

Recently, Oz announced the launch of the Medicare GLP-1 Bridge program, which will enable more seniors to access GLP-1 drugs for a monthly cost of $50, provided they meet qualifying health criteria and receive prior authorization from a doctor. He noted, "There are a lot of overweight people who don't have high blood pressure, diabetes or other conditions, so they don't get access to the drug normally."

Sources